19 February 2020
18 February 2020
GNA Biosolutions has secured $13.5 million from its Series C funding round to advance development and secure IVD-CE marking of its first point-of-care molecular diagnostic platform.
Genomics has been revolutionary – but have we forgotten cell biology in the push for an ever more reductive understanding of health and disease? Professor John S Torday thinks the key, not just to ma…